Gerald B. Pier
Founder at Alopexx Enterprises LLC
Profile
Gerald B.
Pier was the founder of Alopexx, Inc. (founded in 2019) and served as the Chief Scientific Advisor.
Dr. Pier is also the founder of Alopexx Enterprises LLC.
Currently, Dr. Pier is a Professor at Harvard Medical School.
In terms of education, Dr. Pier holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of the Pacific.
Gerald B. Pier active positions
Companies | Position | Start |
---|---|---|
Harvard Medical School | Corporate Officer/Principal | - |
Alopexx Enterprises LLC
Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Founder | - |
Former positions of Gerald B. Pier
Companies | Position | End |
---|---|---|
ALOPEXX, INC. | Founder | - |
Training of Gerald B. Pier
University of the Pacific | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Alopexx, Inc.
Alopexx, Inc. BiotechnologyHealth Technology Alopexx, Inc. develops novel, broad-spectrum immune medicated therapeutics for the prevention and treatment of bacterial, fungal and parasitic microbial infections. The company was founded by Daniel R. Vlock and Gerald B. Pier and is headquartered in Cambridge, MA. | Health Technology |
Alopexx Enterprises LLC
Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Health Technology |
- Stock Market
- Insiders
- Gerald B. Pier